Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
The Schall Law Firm Urges Public Participation In An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations
10:30am, Friday, 06'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm
02:15pm, Thursday, 05'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations
04:30pm, Wednesday, 04'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
Can Adma Biologics (ADMA) Climb 25.5% to Reach the Level Wall Street Analysts Expect?
10:56am, Wednesday, 04'th Dec 2024
The mean of analysts' price targets for Adma Biologics (ADMA) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among a
ADMA Biologics, Inc. Is Being Looked Into For Securities Fraud And Investors With Losses Are Invited To Assist The Schall Law Firm
03:15pm, Tuesday, 03'rd Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
03:21pm, Monday, 02'nd Dec 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV
08:30am, Monday, 02'nd Dec 2024
ADMA Biologics is a rapidly growing player in plasma-derived therapies, with a 78% YoY revenue increase and a 1,300% YoY net income boost. The company's key product, ASCENIV, is expected to drive sign
ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm
03:15pm, Sunday, 01'st Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
The Schall Law Firm Encourages Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations
11:00am, Saturday, 30'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologic
LOS ANGELES, CA / ACCESSWIRE / November 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologic
The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Securities Law Violations
12:45pm, Wednesday, 27'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologic
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
12:15pm, Wednesday, 27'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). Such investors are advised
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
10:40am, Wednesday, 27'th Nov 2024
Here is how Adma Biologics (ADMA) and Addex Therapeutics Ltd. Sponsored ADR (ADXN) have performed compared to their sector so far this year.
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable
09:51am, Wednesday, 27'th Nov 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Adma Biologics (ADMA) could be a great choice. It is one of the several stocks that passed through our "Recent
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
08:45pm, Tuesday, 26'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). Such investors are advised
